ArticleCancer drug resistance (Alhambra, Calif.)2019

Liquid biopsy: expanding the frontier of circulating biomarker discovery and validation in breast cancer.

Philip C Miller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.